SEI Investments
ORKA icon

SEI Investments’s Oruka Therapeutics ORKA Stock Holding History

SEI Investments’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.06M Sell
12,781
-3,977
-24% -$375K ﹤0.01% 2270
2026
Q2 		$1.59M Sell
16,758
-6,082
-27% -$405K ﹤0.01% 2065
2026
Q1 		$1.12M Buy
22,840
+13,164
+136% +$457K ﹤0.01% 2309
2025
Q4 		$293K Buy
+9,676
New +$270K ﹤0.01% 2755

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

SEI Investments's ORKA Position: Q3 2026 in Review

SEI Investments reduced its Oruka Therapeutics (ORKA) stake by 24% in Q3 2026, selling an estimated $375K and leaving 12,781 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2270.

SEI Investments first reported a position in ORKA in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.59M in Q2 2026. 102 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • SEI Investments held 12,781 shares of Oruka Therapeutics worth $1.06M as of Q3 2026.
  • SEI Investments sold 3,977 Oruka Therapeutics shares in Q3 2026, an estimated $375K.
  • Oruka Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2270 holding.
  • SEI Investments first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • SEI Investments's Oruka Therapeutics position peaked at $1.59M in Q2 2026.
  • 102 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.